CORC

在结果中检索

CORC

浏览/检索结果: 共72条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Role of FUS-CHOP in Myxoid Liposarcoma via miR-486/CDK4 Axis 期刊论文
BIOCHEMICAL GENETICS, 2021
作者:  Wu, Hao;  Xia, Liming;  Xu, Haichao
收藏  |  浏览/下载：37/0  |  提交时间：2022/01/10
Acid-activatible micelleplex delivering siRNA-PD-L1 for improved cancer immunotherapy of CDK4/6 inhibition 期刊论文
CHINESE CHEMICAL LETTERS, 2021, 卷号: 32, 期号: 6, 页码: 1929-1936
作者:  Gao, Jing;  Zhang, Hanwu;  Zhou, Fengqi;  Hou, Bo;  Chen, Meiwan
收藏  |  浏览/下载：17/0  |  提交时间：2021/08/17
Arsenic trioxide (ATO) induced degradation of Cyclin D1 sensitized PD-1/PD-L1 checkpoint inhibitor in oral and esophageal squamous cell carcinoma 期刊论文
JOURNAL OF CANCER, 2020, 卷号: 11
作者:  Zhu, Guanxia;  Li, Xia;  Li, Jiong;  Zhou, Wei;  Chen, Zhongjian
收藏  |  浏览/下载：17/0  |  提交时间：2020/11/30
Circular RNA hsa_circ_0016788 regulates hepatocellular carcinoma tumorigenesis through miR-486/CDK4 pathway. 期刊论文
Journal of cellular physiology, 2019, 卷号: 234, 页码: 500-508
作者:  Guan Zheng;  Tan Jing;  Gao Wei;  Li Xin;  Yang Yuandong
收藏  |  浏览/下载：14/0  |  提交时间：2019/11/19
Ribociclib, a selective cyclin D kinase 4/6 inhibitor, inhibits proliferation and induces apoptosis of human cervical cancer in vitro and in vivo 期刊论文
BIOMEDICINE & PHARMACOTHERAPY, 2019, 卷号: 112
作者:  Xiong, Yudi;  Li, Tianqi;  Assani, Ganiou;  Ling, Huan;  Zhou, Qian
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
Ribociclib, a selective cyclin D kinase 4/6 inhibitor, inhibits proliferation and induces apoptosis of human cervical cancer in vitro and in vivo. 期刊论文
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, 卷号: Vol.112, 页码: 108602
作者:  Yudi Xiong;  Tianqi Li;  Ganiou Assani;  Huan Ling;  Qian Zhou
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/17
CDK4  CDK6  Cell  apoptosis  Cell  cycle  Cervical  cancer  Ribociclib  
Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-kappa B Activation and PD-L1 Expression 期刊论文
MOLECULAR CELL, 2019, 卷号: 73, 期号: 1, 页码: 22-+
作者:  Jin, Xin[1];  Ding, Donglin[2];  Yan, Yuqian[3];  Li, Hui[4];  Wang, Bo[5]
收藏  |  浏览/下载：22/0  |  提交时间：2019/12/24
Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer 期刊论文
Cancer Biology and Medicine, 2019, 卷号: 16, 期号: 1, 页码: 66
作者:  Wang Yuxiang;  Li Xian;  Liu Xueling;  Chen Yi;  Yang Chunhao
收藏  |  浏览/下载：13/0  |  提交时间：2020/12/24
PI3Kα  CDK4/6  KRAS  NSCLC  CYH33  
simultaneousinhibitionofpi3kandcdk46synergisticallysuppresseskrasmutatednonsmallcelllungcancer 期刊论文
癌症生物学与医学英文版, 2019, 卷号: 016, 期号: 001, 页码: 66
作者:  Yuxiang Wang;  Xian Li;  Xueling Liu;  Yi Chen;  Chunhao Yang
收藏  |  浏览/下载：13/0  |  提交时间：2020/07/01
PI3Kα  CDK4/6  KRAS  NSCLC  CYH33  
Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 148, 页码: 140-153
作者:  Zha, Chuantao;  Deng, Wenjia;  Fu, Yan;  Tang, Shuai;  Lan, Xiaojing
收藏  |  浏览/下载：68/0  |  提交时间：2019/01/08

©版权所有 ©2017 CSpace - Powered by CSpace